Search Results 1001-1010 of 10333 for total t4
About this study. A global multicenter, randomized, double-blind, placebo-controlled, pivotal phase III study. To evaluate overall survival (OS) of ...
This applies even if the subject practices complete and continued sexual abstinence. ... Serum total bilirubin >2.0 mg/dL (with the exception of Gilbert's ...
... complete or partial remission. A standard treatment is considered not well tolerated if the patient experiences severe side effects without providing an ...
An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20442918.
The purpose of this study is to determine if Regorafenib improves overall survival in refractory AGEC A randomized phase III, double-blind, placebo-controlled ...
... complete four study visits. Your first two study visits as described above will be completed at the beginning of cardiac rehabilitation and then we will ask ...
The purpose of this study is to determine: if the artificial intelligence (AI)-generated results are less arduous than manual tracing by radiation oncologist, ...
The goal is to have the whole team ready for the patient prior to the patient's arrival. When additional specialty services not included in the initial TTA ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.